Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C60H72N10O10S2 |
Molecular Weight | 1157.405 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CC[C@H]7CC[C@H](N7C(=O)[C@H](C6)NC(=O)[C@H](C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9
InChI
InChIKey=AKLBERUGKZNEJY-RTEPGWBGSA-N
InChI=1S/C60H72N10O10S2/c1-39(61-3)55(71)63-49-37-67(34-32-45-28-30-51(69(45)59(49)75)57(73)65-53(41-18-9-5-10-19-41)42-20-11-6-12-21-42)81(77,78)47-26-17-27-48(36-47)82(79,80)68-35-33-46-29-31-52(70(46)60(76)50(38-68)64-56(72)40(2)62-4)58(74)66-54(43-22-13-7-14-23-43)44-24-15-8-16-25-44/h5-27,36,39-40,45-46,49-54,61-62H,28-35,37-38H2,1-4H3,(H,63,71)(H,64,72)(H,65,73)(H,66,74)/t39-,40-,45+,46+,49-,50-,51-,52-/m0/s1
Molecular Formula | C60H72N10O10S2 |
Molecular Weight | 1157.405 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 21:08:45 GMT 2025
by
admin
on
Tue Apr 01 21:08:45 GMT 2025
|
Record UNII |
E53VN70K2X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
E53VN70K2X
Created by
admin on Tue Apr 01 21:08:45 GMT 2025 , Edited by admin on Tue Apr 01 21:08:45 GMT 2025
|
PRIMARY | |||
|
E53VN70K2X
Created by
admin on Tue Apr 01 21:08:45 GMT 2025 , Edited by admin on Tue Apr 01 21:08:45 GMT 2025
|
PRIMARY | |||
|
1570231-89-8
Created by
admin on Tue Apr 01 21:08:45 GMT 2025 , Edited by admin on Tue Apr 01 21:08:45 GMT 2025
|
PRIMARY | |||
|
300000020851
Created by
admin on Tue Apr 01 21:08:45 GMT 2025 , Edited by admin on Tue Apr 01 21:08:45 GMT 2025
|
PRIMARY | |||
|
12430
Created by
admin on Tue Apr 01 21:08:45 GMT 2025 , Edited by admin on Tue Apr 01 21:08:45 GMT 2025
|
PRIMARY | |||
|
C162535
Created by
admin on Tue Apr 01 21:08:45 GMT 2025 , Edited by admin on Tue Apr 01 21:08:45 GMT 2025
|
PRIMARY | |||
|
73336238
Created by
admin on Tue Apr 01 21:08:45 GMT 2025 , Edited by admin on Tue Apr 01 21:08:45 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
APG-1387 in combination with TNF-? potently decreased NPC cell viability by inducing apoptosis in majority of NPC cell lines. Eight human IAP proteins and Smac mimetics activate caspases by antagonizing XIAP, which directly inhibits key caspase.
|
||
|
TARGET -> INHIBITOR |
APG-1387 in combination with TNF-? potently decreased NPC cell viability by inducing apoptosis in majority of NPC cell lines. Eight human IAP proteins and Smac mimetics activate caspases by antagonizing XIAP, which directly inhibits key caspase.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|